Synendos is a clinical-stage neuroscience company developing breakthrough therapies for neuropsychiatric disorders, focusing on anxiety and mood-related conditions by targeting the Endocannabinoid System
Synendos is a clinical-stage neuroscience company developing breakthrough therapies for neuropsychiatric disorders, focusing on anxiety and mood-related conditions by targeting the Endocannabinoid System.